Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Clinical trial NCT01200992 · TERMINATED

Trial details

NCT number: NCT01200992
Sponsor: Bioniche Life Sciences Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder Neoplasm Neoplasm Recurrence, Local Transitional Cell, Carcinoma Carcinoma in Situ Mycobacterium

Start date: 2010-11-01
Primary completion: 2013-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.